Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center

Patrick Hoversten, Fouad Otaki, David A Katzka

Research output: Contribution to journalShort survey

3 Scopus citations


Candida infection in the gastrointestinal tract is most studied in immunocompromised patients. Patients without systemic immunodeficiency, however, may have esophageal candidiasis associated with antibiotic or steroid medication use, alcoholic consumption, diabetes mellitus, and esophageal stasis disorders such achalasia or scleroderma esophagus.1–5 This population has not been well studied. We aim to describe demographics, risk factors, and relevant clinical outcomes for patients with Candida esophagitis with an emphasis in systemically immunocompetent patients.

Original languageEnglish (US)
Pages (from-to)200-202.e1
JournalClinical Gastroenterology and Hepatology
Issue number1
StatePublished - Jan 1 2019


ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this